Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
11,879
datasets available to search
ShareScore release 0.9.0
Dataset results
11,879 results for “participation”
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
ClinicalTrials.gov study NCT03797326. IPD Sharing: YES. Countries: 17. Publications: 3.
Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Diabetic Peripheral Neuropathic Pain
ClinicalTrials.gov study NCT04476108. IPD Sharing: YES. Countries: 2. Publications: 1.
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
ClinicalTrials.gov study NCT05831176. IPD Sharing: YES. Countries: 4. Publications: 1.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT03823391. IPD Sharing: YES. Countries: 7. Publications: 1.
A Continuation Study of Herceptin (Trastuzumab) in Participants With Metastatic or Locally Advanced Cancer
ClinicalTrials.gov study NCT02721641. IPD Sharing: Not stated. Countries: 17. Publications: 1.
A Study to Determine Dose, Safety, Tolerability, Drug Levels, and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT02773030. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Study of ASTX727 vs IV Decitabine in Participants With MDS, CMML, and AML
ClinicalTrials.gov study NCT03306264. IPD Sharing: NO. Countries: 10. Publications: 1.
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors
ClinicalTrials.gov study NCT02622321. IPD Sharing: Not stated. Countries: 14. Publications: 2.
Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis
ClinicalTrials.gov study NCT03737110. IPD Sharing: NO. Countries: 4. Publications: 8.
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
ClinicalTrials.gov study NCT01875003. IPD Sharing: Not stated. Countries: 23. Publications: 1.
A Study of LY3462817 in Participants With Rheumatoid Arthritis
ClinicalTrials.gov study NCT04634253. IPD Sharing: YES. Countries: 7. Publications: 2.
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
ClinicalTrials.gov study NCT04919512. IPD Sharing: YES. Countries: 10. Publications: 2.
A Study of INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer
ClinicalTrials.gov study NCT02172911. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02807558. IPD Sharing: NO. Countries: 2. Publications: 1.
Safety and Efficacy of GS-4774 in Combination With Tenofovir Disoproxil Fumarate (TDF) for the Treatment of Participants With Chronic Hepatitis B (CHB) and Who Are Currently Not on Treatment
ClinicalTrials.gov study NCT02174276. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
ClinicalTrials.gov study NCT05268289. IPD Sharing: YES. Countries: 20. Publications: 1.
A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03443024. IPD Sharing: YES. Countries: 1. Publications: 2.
An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis
ClinicalTrials.gov study NCT02497469. IPD Sharing: YES. Countries: 34. Publications: 3.
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Meta
ClinicalTrials.gov study NCT02257736. IPD Sharing: Not stated. Countries: 16. Publications: 2.
Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)
ClinicalTrials.gov study NCT03852433. IPD Sharing: NO. Countries: 4. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.